Symbols / NEO $8.02 +0.25% NeoGenomics, Inc.
NEO Chart
About
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company offers molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. The company was founded in 2001 and is headquartered in Fort Myers, Florida.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Diagnostics & Research | Market Cap | 1.04B |
| Enterprise Value | 1.29B | Income | -108.03M | Sales | 727.33M |
| Book/sh | 6.49 | Cash/sh | 1.23 | Dividend Yield | — |
| Payout | 0.00% | Employees | 2500 | IPO | — |
| P/E | — | Forward P/E | 25.13 | PEG | — |
| P/S | 1.43 | P/B | 1.24 | P/C | — |
| EV/EBITDA | -707.49 | EV/Sales | 1.77 | Quick Ratio | 3.61 |
| Current Ratio | 4.26 | Debt/Eq | 48.95 | LT Debt/Eq | — |
| EPS (ttm) | -0.84 | EPS next Y | 0.32 | EPS Growth | — |
| Revenue Growth | 10.60% | Earnings | 2026-04-28 | ROA | -2.90% |
| ROE | -12.43% | ROIC | — | Gross Margin | 43.16% |
| Oper. Margin | -6.56% | Profit Margin | -14.85% | Shs Outstand | 129.81M |
| Shs Float | 119.30M | Short Float | 8.88% | Short Ratio | 4.21 |
| Short Interest | — | 52W High | 13.74 | 52W Low | 4.72 |
| Beta | 1.71 | Avg Volume | 1.86M | Volume | 1.71M |
| Target Price | $14.81 | Recom | Buy | Prev Close | $8.00 |
| Price | $8.02 | Change | 0.25% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-02-24 | main | Piper Sandler | Overweight → Overweight | $13 |
| 2026-02-17 | main | Needham | Buy → Buy | $15 |
| 2026-01-12 | reit | Needham | Buy → Buy | $14 |
| 2025-09-12 | main | TD Cowen | Buy → Buy | $12 |
| 2025-09-02 | main | Stephens & Co. | Overweight → Overweight | $11 |
| 2025-08-29 | main | Needham | Buy → Buy | $14 |
| 2025-08-04 | main | Piper Sandler | Overweight → Overweight | $11 |
| 2025-07-30 | main | Morgan Stanley | Equal-Weight → Equal-Weight | $8 |
| 2025-07-29 | down | William Blair | Outperform → Market Perform | — |
| 2025-07-29 | main | Needham | Buy → Buy | $8 |
| 2025-05-06 | main | Piper Sandler | Overweight → Overweight | $12 |
| 2025-05-01 | main | Morgan Stanley | Equal-Weight → Equal-Weight | $10 |
| 2025-04-30 | main | Goldman Sachs | Buy → Buy | $10 |
| 2025-04-30 | down | Leerink Partners | Outperform → Market Perform | $9 |
| 2025-04-29 | main | Needham | Buy → Buy | $9 |
| 2025-04-17 | main | Goldman Sachs | Buy → Buy | $15 |
| 2025-02-26 | main | Piper Sandler | Overweight → Overweight | $18 |
| 2025-02-19 | main | B of A Securities | Neutral → Neutral | $16 |
| 2025-02-19 | main | Needham | Buy → Buy | $18 |
| 2025-01-28 | main | Goldman Sachs | Buy → Buy | $18 |
News
RSS: Latest NEO news- Apple’s stock could surge 20%, and the MacBook Neo could be a key catalyst - MarketWatch Mon, 06 Apr 2026 16
- NEOGENOMICS INC ($NEO) CEO 2025 Pay Revealed - Quiver Quantitative Mon, 06 Apr 2026 21
- BofA reiterates Buy on Apple stock on MacBook Neo launch - Investing.com Mon, 06 Apr 2026 10
- NeoGenomics (NASDAQ: NEO) seeks approval to expand 2023 equity incentive plan - Stock Titan Mon, 06 Apr 2026 20
- Apple stock could surge at least 20% as MacBook Neo emerges as major catalyst - MacDailyNews Mon, 06 Apr 2026 21
- Aberdeen Group plc Buys 1,006,676 Shares of NeoGenomics, Inc. $NEO - MarketBeat Mon, 06 Apr 2026 07
- The Neocloud Supercycle Is Here. This Growth Stock Could Be Its Biggest Winner. - The Motley Fool hu, 02 Apr 2026 19
- Why NeoGenomics (NEO) Shares Are Falling Today - Yahoo Finance Wed, 18 Feb 2026 08
- SIZE.NE Major Precious Metals Corp. (NEO) volume hits 494,426 on 06 Apr 2026: model sees C$0.07 upside - Meyka Mon, 06 Apr 2026 09
- NeoGenomics (NEO) CEO exercises RSUs and uses shares to cover taxes - Stock Titan Fri, 03 Apr 2026 20
- NeoGenomics (NASDAQ:NEO) Stock Price Down 7.9% - Should You Sell? - MarketBeat hu, 12 Mar 2026 07
- Neo Performance Materials Inc. (NOPMF) Stock Jumps 12.9%: Will It Continue to Soar? - Yahoo Finance Wed, 25 Feb 2026 08
- NeoGenomics (NEO) COO nets shares after 17,562-unit RSU vesting - Stock Titan Fri, 03 Apr 2026 20
- NEO May 2026 9.000 call (NEO260515C00009000) Interactive Stock Chart - Yahoo! Finance Canada hu, 02 Apr 2026 18
- NEO May 2026 14.000 put (NEO260515P00014000) Stock Historical Prices & Data - Yahoo! Finance Canada hu, 02 Apr 2026 13
Insider Transactions
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
727.33
+10.11%
|
660.57
+11.65%
|
591.64
+16.07%
|
509.73
|
| Operating Revenue |
|
727.33
+10.11%
|
660.57
+11.65%
|
591.64
+16.07%
|
509.73
|
| Cost Of Revenue |
|
413.04
+11.49%
|
370.47
+6.75%
|
347.04
+7.83%
|
321.83
|
| Reconciled Cost Of Revenue |
|
378.91
+14.19%
|
331.81
+7.58%
|
308.44
+8.16%
|
285.17
|
| Gross Profit |
|
314.29
+8.34%
|
290.10
+18.60%
|
244.60
+30.18%
|
187.90
|
| Operating Expense |
|
402.42
+7.16%
|
375.55
+10.05%
|
341.25
+0.07%
|
341.00
|
| Research And Development |
|
37.08
+18.99%
|
31.16
+14.10%
|
27.31
-9.95%
|
30.33
|
| Selling General And Administration |
|
331.65
+6.81%
|
310.49
+10.91%
|
279.96
+0.74%
|
277.91
|
| Selling And Marketing Expense |
|
91.92
+8.62%
|
84.62
+19.46%
|
70.84
+5.23%
|
67.32
|
| General And Administrative Expense |
|
239.74
+6.14%
|
225.87
+8.01%
|
209.12
-0.70%
|
210.59
|
| Other Gand A |
|
239.74
+6.14%
|
225.87
+8.01%
|
209.12
-0.70%
|
210.59
|
| Total Expenses |
|
815.46
+9.31%
|
746.01
+8.39%
|
688.29
+3.84%
|
662.84
|
| Operating Income |
|
-88.13
-3.14%
|
-85.45
+11.59%
|
-96.65
+36.88%
|
-153.11
|
| Total Operating Income As Reported |
|
-115.88
-25.81%
|
-92.11
+14.51%
|
-107.74
+31.65%
|
-157.62
|
| EBITDA |
|
-38.69
-2460.62%
|
-1.51
+91.42%
|
-17.61
+78.61%
|
-82.33
|
| Normalized EBITDA |
|
-10.94
-312.51%
|
5.15
+178.95%
|
-6.52
+91.62%
|
-77.81
|
| Reconciled Depreciation |
|
67.82
-6.51%
|
72.55
-0.05%
|
72.58
+4.54%
|
69.43
|
| EBIT |
|
-106.52
-43.83%
|
-74.06
+17.89%
|
-90.19
+40.57%
|
-151.76
|
| Total Unusual Items |
|
-27.75
-316.84%
|
-6.66
+39.95%
|
-11.09
-145.53%
|
-4.52
|
| Total Unusual Items Excluding Goodwill |
|
-27.75
-316.84%
|
-6.66
+39.95%
|
-11.09
-145.53%
|
-4.52
|
| Special Income Charges |
|
-27.75
-316.84%
|
-6.66
+39.95%
|
-11.09
-145.53%
|
-4.52
|
| Impairment Of Capital Assets |
|
27.75
|
0.00
|
0.00
|
—
|
| Restructuring And Mergern Acquisition |
|
0.00
-100.00%
|
6.66
-39.95%
|
11.09
+145.53%
|
4.52
|
| Net Income |
|
-108.03
-37.22%
|
-78.73
+10.51%
|
-87.97
+39.02%
|
-144.25
|
| Pretax Income |
|
-110.27
-36.68%
|
-80.67
+16.91%
|
-97.10
+39.06%
|
-159.34
|
| Net Non Operating Interest Income Expense |
|
5.32
-54.98%
|
11.81
+18.16%
|
9.99
+763.68%
|
-1.51
|
| Interest Expense Non Operating |
|
3.75
-43.28%
|
6.62
-4.20%
|
6.91
-8.89%
|
7.58
|
| Net Interest Income |
|
5.32
-54.98%
|
11.81
+18.16%
|
9.99
+763.68%
|
-1.51
|
| Interest Expense |
|
3.75
-43.28%
|
6.62
-4.20%
|
6.91
-8.89%
|
7.58
|
| Interest Income Non Operating |
|
9.07
-50.78%
|
18.43
+9.02%
|
16.90
+178.22%
|
6.08
|
| Interest Income |
|
9.07
-50.78%
|
18.43
+9.02%
|
16.90
+178.22%
|
6.08
|
| Other Income Expense |
|
-27.46
-290.18%
|
-7.04
+32.62%
|
-10.44
-120.85%
|
-4.73
|
| Other Non Operating Income Expenses |
|
0.30
+178.10%
|
-0.38
-158.85%
|
0.64
+402.35%
|
-0.21
|
| Tax Provision |
|
-2.24
-15.08%
|
-1.95
+78.65%
|
-9.13
+39.51%
|
-15.09
|
| Tax Rate For Calcs |
|
0.00
-16.12%
|
0.00
-74.26%
|
0.00
-0.63%
|
0.00
|
| Tax Effect Of Unusual Items |
|
-0.56
-249.66%
|
-0.16
+84.54%
|
-1.04
-143.97%
|
-0.43
|
| Net Income Including Noncontrolling Interests |
|
-108.03
-37.22%
|
-78.73
+10.51%
|
-87.97
+39.02%
|
-144.25
|
| Net Income From Continuing Operation Net Minority Interest |
|
-108.03
-37.22%
|
-78.73
+10.51%
|
-87.97
+39.02%
|
-144.25
|
| Net Income From Continuing And Discontinued Operation |
|
-108.03
-37.22%
|
-78.73
+10.51%
|
-87.97
+39.02%
|
-144.25
|
| Net Income Continuous Operations |
|
-108.03
-37.22%
|
-78.73
+10.51%
|
-87.97
+39.02%
|
-144.25
|
| Normalized Income |
|
-80.84
-11.92%
|
-72.23
+7.31%
|
-77.92
+44.41%
|
-140.16
|
| Net Income Common Stockholders |
|
-108.03
-37.22%
|
-78.73
+10.51%
|
-87.97
+39.02%
|
-144.25
|
| Diluted EPS |
|
-0.84
-35.48%
|
-0.62
+11.43%
|
-0.70
+39.66%
|
-1.16
|
| Basic EPS |
|
-0.84
-35.48%
|
-0.62
+11.43%
|
-0.70
+39.66%
|
-1.16
|
| Basic Average Shares |
|
128.10
+1.14%
|
126.66
+0.92%
|
125.50
+1.03%
|
124.22
|
| Diluted Average Shares |
|
128.10
+1.14%
|
126.66
+0.92%
|
125.50
+1.03%
|
124.22
|
| Diluted NI Availto Com Stockholders |
|
-108.03
-37.22%
|
-78.73
+10.51%
|
-87.97
+39.02%
|
-144.25
|
| Amortization |
|
12.80
-7.27%
|
13.81
-10.89%
|
15.49
+5.80%
|
14.65
|
| Amortization Of Intangibles Income Statement |
|
12.80
-7.27%
|
13.81
-10.89%
|
15.49
+5.80%
|
14.65
|
| Depreciation Amortization Depletion Income Statement |
|
33.69
-0.60%
|
33.90
-0.26%
|
33.98
+3.70%
|
32.77
|
| Depreciation And Amortization In Income Statement |
|
33.69
-0.60%
|
33.90
-0.26%
|
33.98
+3.70%
|
32.77
|
| Depreciation Income Statement |
|
20.89
+3.99%
|
20.09
+8.65%
|
18.49
+2.01%
|
18.12
|
| Earnings From Equity Interest |
|
—
|
—
|
0.00
|
0.00
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
1,359.83
-16.98%
|
1,638.04
-2.57%
|
1,681.23
-3.38%
|
1,740.03
|
| Current Assets |
|
376.29
-36.87%
|
596.02
-0.13%
|
596.81
-1.40%
|
605.29
|
| Cash Cash Equivalents And Short Term Investments |
|
159.62
-58.74%
|
386.84
-6.83%
|
415.20
-5.20%
|
437.99
|
| Cash And Cash Equivalents |
|
159.62
-56.51%
|
367.01
+7.16%
|
342.49
+30.13%
|
263.18
|
| Other Short Term Investments |
|
0.00
-100.00%
|
19.83
-72.73%
|
72.72
-58.40%
|
174.81
|
| Receivables |
|
159.24
+5.78%
|
150.54
+14.72%
|
131.23
+9.62%
|
119.71
|
| Accounts Receivable |
|
159.24
+5.78%
|
150.54
+14.72%
|
131.23
+9.62%
|
119.71
|
| Inventory |
|
28.57
+6.80%
|
26.75
+10.73%
|
24.16
-0.50%
|
24.28
|
| Prepaid Assets |
|
21.44
+6.34%
|
20.16
+12.11%
|
17.99
+18.05%
|
15.24
|
| Assets Held For Sale Current |
|
—
|
—
|
—
|
0.00
|
| Other Current Assets |
|
7.42
-36.73%
|
11.72
+42.27%
|
8.24
+2.01%
|
8.08
|
| Total Non Current Assets |
|
983.54
-5.61%
|
1,042.02
-3.91%
|
1,084.42
-4.44%
|
1,134.74
|
| Net PPE |
|
163.28
-5.99%
|
173.69
-5.49%
|
183.78
-7.47%
|
198.61
|
| Gross PPE |
|
372.33
+2.38%
|
363.68
+6.34%
|
341.99
+3.47%
|
330.54
|
| Accumulated Depreciation |
|
-209.06
-10.04%
|
-189.99
-20.09%
|
-158.21
-19.92%
|
-131.93
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Land And Improvements |
|
—
|
—
|
—
|
—
|
| Buildings And Improvements |
|
—
|
—
|
—
|
—
|
| Machinery Furniture Equipment |
|
122.51
+5.00%
|
116.67
+18.06%
|
98.82
+10.70%
|
89.27
|
| Construction In Progress |
|
7.73
-9.21%
|
8.51
+135.63%
|
3.61
-59.80%
|
8.98
|
| Other Properties |
|
182.69
+0.98%
|
180.92
-4.94%
|
190.33
+1.31%
|
187.87
|
| Leases |
|
59.41
+3.19%
|
57.57
+16.95%
|
49.23
+10.83%
|
44.42
|
| Goodwill And Other Intangible Assets |
|
810.87
-5.98%
|
862.45
-3.73%
|
895.89
-3.77%
|
931.03
|
| Goodwill |
|
524.34
+0.30%
|
522.77
+0.00%
|
522.77
+0.00%
|
522.77
|
| Other Intangible Assets |
|
286.53
-15.65%
|
339.68
-8.96%
|
373.13
-8.61%
|
408.26
|
| Investments And Advances |
|
—
|
—
|
—
|
—
|
| Long Term Equity Investment |
|
—
|
—
|
—
|
—
|
| Other Non Current Assets |
|
9.39
+59.60%
|
5.89
+24.12%
|
4.74
-7.18%
|
5.11
|
| Total Liabilities Net Minority Interest |
|
523.27
-28.87%
|
735.70
-0.54%
|
739.69
-0.31%
|
742.01
|
| Current Liabilities |
|
88.30
-70.69%
|
301.24
+212.80%
|
96.30
+7.09%
|
89.93
|
| Payables And Accrued Expenses |
|
35.09
+2.52%
|
34.23
-3.31%
|
35.40
-0.50%
|
35.58
|
| Payables |
|
23.09
+6.86%
|
21.61
+6.26%
|
20.33
-0.86%
|
20.51
|
| Accounts Payable |
|
23.09
+6.86%
|
21.61
+6.26%
|
20.33
-0.86%
|
20.51
|
| Current Accrued Expenses |
|
12.00
-4.92%
|
12.62
-16.23%
|
15.07
-0.01%
|
15.07
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
47.58
-23.80%
|
62.44
+17.46%
|
53.16
+32.44%
|
40.14
|
| Current Debt And Capital Lease Obligation |
|
4.78
-97.66%
|
204.16
+3539.18%
|
5.61
-15.69%
|
6.65
|
| Current Debt |
|
—
|
200.78
|
—
|
—
|
| Other Current Borrowings |
|
—
|
200.78
|
—
|
—
|
| Current Capital Lease Obligation |
|
4.78
+41.26%
|
3.38
-39.73%
|
5.61
-15.69%
|
6.65
|
| Current Deferred Liabilities |
|
0.85
+108.07%
|
0.41
-80.80%
|
2.13
-71.81%
|
7.56
|
| Current Deferred Revenue |
|
0.85
+108.07%
|
0.41
-80.80%
|
2.13
-71.81%
|
7.56
|
| Total Non Current Liabilities Net Minority Interest |
|
434.97
+0.12%
|
434.46
-32.47%
|
643.39
-1.33%
|
652.08
|
| Long Term Debt And Capital Lease Obligation |
|
404.68
+0.87%
|
401.18
-33.81%
|
606.07
+0.30%
|
604.27
|
| Long Term Debt |
|
341.86
+0.45%
|
340.33
-36.76%
|
538.20
+0.54%
|
535.32
|
| Long Term Capital Lease Obligation |
|
62.82
+3.26%
|
60.84
-10.36%
|
67.87
-1.57%
|
68.95
|
| Non Current Deferred Liabilities |
|
18.22
-15.30%
|
21.51
-11.43%
|
24.29
-30.12%
|
34.75
|
| Non Current Deferred Taxes Liabilities |
|
18.22
-15.30%
|
21.51
-11.43%
|
24.29
-30.12%
|
34.75
|
| Other Non Current Liabilities |
|
12.07
+2.52%
|
11.77
-9.68%
|
13.03
-0.16%
|
13.05
|
| Stockholders Equity |
|
836.56
-7.29%
|
902.34
-4.16%
|
941.54
-5.66%
|
998.02
|
| Common Stock Equity |
|
836.56
-7.29%
|
902.34
-4.16%
|
941.54
-5.66%
|
998.02
|
| Capital Stock |
|
0.13
+0.78%
|
0.13
+0.79%
|
0.13
+0.00%
|
0.13
|
| Common Stock |
|
0.13
+0.78%
|
0.13
+0.79%
|
0.13
+0.00%
|
0.13
|
| Share Issued |
|
128.99
+0.66%
|
128.15
+0.61%
|
127.37
+0.36%
|
126.91
|
| Ordinary Shares Number |
|
128.99
+0.66%
|
128.15
+0.61%
|
127.37
+0.36%
|
126.91
|
| Additional Paid In Capital |
|
1,270.23
+3.42%
|
1,228.20
+3.20%
|
1,190.14
+2.52%
|
1,160.88
|
| Retained Earnings |
|
-433.81
-33.16%
|
-325.78
-31.87%
|
-247.06
-55.30%
|
-159.09
|
| Gains Losses Not Affecting Retained Earnings |
|
0.00
+101.94%
|
-0.21
+87.69%
|
-1.67
+57.07%
|
-3.90
|
| Other Equity Adjustments |
|
0.00
+101.94%
|
-0.21
+87.69%
|
-1.67
+57.07%
|
-3.90
|
| Total Equity Gross Minority Interest |
|
836.56
-7.29%
|
902.34
-4.16%
|
941.54
-5.66%
|
998.02
|
| Total Capitalization |
|
1,178.42
-5.17%
|
1,242.67
-16.02%
|
1,479.73
-3.50%
|
1,533.35
|
| Working Capital |
|
287.99
-2.30%
|
294.78
-41.10%
|
500.51
-2.88%
|
515.36
|
| Invested Capital |
|
1,178.42
-18.36%
|
1,443.45
-2.45%
|
1,479.73
-3.50%
|
1,533.35
|
| Total Debt |
|
409.46
-32.36%
|
605.33
-1.04%
|
611.68
+0.12%
|
610.93
|
| Net Debt |
|
182.24
+4.68%
|
174.10
-11.04%
|
195.71
-28.09%
|
272.14
|
| Capital Lease Obligations |
|
67.60
+5.26%
|
64.22
-12.60%
|
73.48
-2.81%
|
75.61
|
| Net Tangible Assets |
|
25.69
-35.60%
|
39.89
-12.60%
|
45.64
-31.87%
|
67.00
|
| Tangible Book Value |
|
25.69
-35.60%
|
39.89
-12.60%
|
45.64
-31.87%
|
67.00
|
| Investmentsin Associatesat Cost |
|
—
|
—
|
—
|
—
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
5.23
-25.53%
|
7.02
+459.60%
|
-1.95
+97.04%
|
-65.99
|
| Cash Flow From Continuing Operating Activities |
|
5.23
-25.53%
|
7.02
+459.60%
|
-1.95
+97.04%
|
-65.99
|
| Net Income From Continuing Operations |
|
-108.03
-37.22%
|
-78.73
+10.51%
|
-87.97
+39.02%
|
-144.25
|
| Depreciation Amortization Depletion |
|
67.82
-6.51%
|
72.55
-0.05%
|
72.58
+4.54%
|
69.43
|
| Depreciation |
|
36.07
-7.75%
|
39.10
+4.41%
|
37.45
+5.87%
|
35.37
|
| Amortization Cash Flow |
|
31.75
-5.06%
|
33.45
-4.80%
|
35.13
+3.16%
|
34.06
|
| Depreciation And Amortization |
|
67.82
-6.51%
|
72.55
-0.05%
|
72.58
+4.54%
|
69.43
|
| Amortization Of Intangibles |
|
31.75
-5.06%
|
33.45
-4.80%
|
35.13
+3.16%
|
34.06
|
| Other Non Cash Items |
|
8.43
-29.89%
|
12.02
-2.27%
|
12.30
-14.18%
|
14.33
|
| Stock Based Compensation |
|
41.32
+23.65%
|
33.41
+35.64%
|
24.63
-0.16%
|
24.67
|
| Asset Impairment Charge |
|
27.75
+6067.33%
|
0.45
-73.58%
|
1.70
+137.19%
|
0.72
|
| Operating Gains Losses |
|
0.03
+163.27%
|
-0.05
-116.78%
|
0.29
-63.95%
|
0.81
|
| Change In Working Capital |
|
-32.09
+1.64%
|
-32.63
-28.00%
|
-25.49
+19.58%
|
-31.70
|
| Change In Receivables |
|
-6.18
+68.01%
|
-19.31
-67.71%
|
-11.52
-51.91%
|
-7.58
|
| Changes In Account Receivables |
|
-6.18
+68.01%
|
-19.31
-67.71%
|
-11.52
-51.91%
|
-7.58
|
| Change In Inventory |
|
-1.54
+42.83%
|
-2.70
-494.49%
|
-0.45
+58.73%
|
-1.10
|
| Change In Prepaid Assets |
|
1.55
+122.76%
|
-6.83
-114.81%
|
-3.18
-174.14%
|
-1.16
|
| Change In Payables And Accrued Expense |
|
-20.36
-485.37%
|
5.28
-37.66%
|
8.47
+203.15%
|
2.79
|
| Change In Accrued Expense |
|
-15.66
-268.75%
|
9.28
-28.70%
|
13.02
+608.76%
|
1.84
|
| Change In Payable |
|
-4.69
-17.22%
|
-4.00
+12.01%
|
-4.55
-574.63%
|
0.96
|
| Change In Account Payable |
|
-4.69
-17.22%
|
-4.00
+12.01%
|
-4.55
-574.63%
|
0.96
|
| Change In Other Working Capital |
|
-3.36
-9.41%
|
-3.07
+72.57%
|
-11.19
+30.47%
|
-16.10
|
| Change In Other Current Assets |
|
—
|
—
|
—
|
-8.56
|
| Change In Other Current Liabilities |
|
-2.21
+63.08%
|
-6.00
+21.30%
|
-7.62
+10.92%
|
-8.56
|
| Investing Cash Flow |
|
-12.34
-195.96%
|
12.86
-83.24%
|
76.71
+14736.94%
|
0.52
|
| Cash Flow From Continuing Investing Activities |
|
-12.34
-195.96%
|
12.86
-83.24%
|
76.71
+14736.94%
|
0.52
|
| Net PPE Purchase And Sale |
|
-27.01
+34.22%
|
-41.06
-42.81%
|
-28.75
+6.92%
|
-30.89
|
| Purchase Of PPE |
|
-27.01
+34.22%
|
-41.06
-42.81%
|
-28.75
+6.92%
|
-30.89
|
| Capital Expenditure |
|
-27.01
+34.22%
|
-41.06
-42.81%
|
-28.75
+6.92%
|
-30.89
|
| Net Investment Purchase And Sale |
|
19.56
-63.72%
|
53.92
-48.87%
|
105.46
+446.14%
|
19.31
|
| Purchase Of Investment |
|
-0.50
|
0.00
+100.00%
|
-6.76
+93.08%
|
-97.61
|
| Sale Of Investment |
|
20.06
-62.79%
|
53.92
-51.95%
|
112.22
-4.02%
|
116.92
|
| Net Business Purchase And Sale |
|
-6.45
|
0.00
|
0.00
|
0.00
|
| Purchase Of Business |
|
-6.45
|
0.00
|
0.00
|
0.00
|
| Net Other Investing Changes |
|
1.57
|
—
|
—
|
12.10
|
| Financing Cash Flow |
|
-200.29
-4410.98%
|
4.65
+2.02%
|
4.55
-61.50%
|
11.83
|
| Cash Flow From Continuing Financing Activities |
|
-200.29
-4410.98%
|
4.65
+2.02%
|
4.55
-61.50%
|
11.83
|
| Net Issuance Payments Of Debt |
|
-201.25
|
0.00
|
0.00
|
0.00
|
| Issuance Of Debt |
|
—
|
—
|
0.00
|
0.00
|
| Repayment Of Debt |
|
-201.25
|
0.00
|
0.00
|
0.00
|
| Long Term Debt Issuance |
|
—
|
—
|
0.00
|
0.00
|
| Long Term Debt Payments |
|
-201.25
|
0.00
|
0.00
|
0.00
|
| Net Long Term Debt Issuance |
|
-201.25
|
0.00
|
0.00
|
0.00
|
| Net Common Stock Issuance |
|
0.96
-79.29%
|
4.65
+0.48%
|
4.62
-63.26%
|
12.59
|
| Net Other Financing Charges |
|
—
|
—
|
-0.07
+90.77%
|
-0.76
|
| Changes In Cash |
|
-207.39
-945.68%
|
24.52
-69.08%
|
79.31
+247.83%
|
-53.65
|
| Beginning Cash Position |
|
367.01
+7.16%
|
342.49
+30.13%
|
263.18
-16.93%
|
316.83
|
| End Cash Position |
|
159.62
-56.51%
|
367.01
+7.16%
|
342.49
+30.13%
|
263.18
|
| Free Cash Flow |
|
-21.78
+36.02%
|
-34.04
-10.85%
|
-30.70
+68.31%
|
-96.88
|
| Interest Paid Supplemental Data |
|
1.69
-55.84%
|
3.83
+13.28%
|
3.38
-0.71%
|
3.40
|
| Income Tax Paid Supplemental Data |
|
0.52
+148.79%
|
0.21
+18.29%
|
0.17
-2.78%
|
0.18
|
| Common Stock Issuance |
|
0.96
-79.29%
|
4.65
+0.48%
|
4.62
-63.26%
|
12.59
|
| Earnings Losses From Equity Investments |
|
—
|
—
|
0.00
|
0.00
|
| Issuance Of Capital Stock |
|
0.96
-79.29%
|
4.65
+0.48%
|
4.62
-63.26%
|
12.59
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42026-04-03 View
- 42026-04-03 View
- 42026-03-03 View
- 42026-03-03 View
- 42026-03-03 View
- 42026-03-03 View
- 42026-02-24 View
- 42026-02-24 View
- 42026-02-24 View
- 42026-02-24 View
- 10-K2026-02-17 View
- 8-K2026-02-17 View
- 42026-01-21 View
- 42026-01-15 View
- 42026-01-15 View
- 8-K2026-01-12 View
- 42026-01-05 View
- 8-K2025-12-30 View
- 42025-12-09 View
- 42025-12-03 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|